The US is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the US — and one that’s already available in Europe and multiple other countries. Nearly a … Read more
The Novavax vaccine is manufactured and marketed in India by SII under the brand name, Covovax. The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Institute of India (SII) Covid-19 vaccine, Covovax, in the 12-18 age group. Covovax is the fourth vaccine to receive EUA from … Read more
UK regulator the MHRA says Nuvaxovid is safe as a first and second dose in adults. Source link
The country has ordered 51 million doses of the U.S.-manufactured vaccine, supplied under the brand Nuvaxovid, for its population of 26 million. Novavax’s COVID-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia.The country has ordered 51 million doses of the U.S.-manufactured vaccine, supplied under the brand Nuvaxovid, for its population … Read more
On November 27, the Subject Expert Committee on COVID-19 had evaluated and deliberated on SII’s application and sought additional data from the company. An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India’s COVID-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash … Read more
The European Medicines Agency decision to grant conditional marketing authorisation for the vaccine for people aged 18 and over comes as many European nations are battling surges in infections and amid concerns about the spread of the new omicron variant. The European Union’s drugs regulator gave the green light Monday to a fifth COVID-19 vaccine … Read more
Adar Poonawalla, the CEO of Serum Institute of India (SII), hailed WHO’s decision as “yet another milestone” in the fight against COVID-19. The World Health Organisation on Friday issued emergency use listing for anti-Covid vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global … Read more
Bharat Biotech thanked the DCGI, SEC and CDSCO for expediting the review process. (Representational image) The vaccine Subject Expert Committee (SEC) on Tuesday recommended granting of emergency use authorisation (EUA) for vaccine maker Bharat Biotech’s Covid-19-vaccine, Covaxin, for children in the 2-18 years age group. The SEC has recommended this to the Drugs Controller General … Read more
The decision means thousands of people who took part in trials will be able to travel abroad. Source link
Participants in the Novavax Covid-19 vaccine trial are not yet recognised as being fully vaccinated. Source link